Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study

Beernink, JM; Persson, F; Jongs, N; Laverman, GD; Chertow, GM; McMurray, JJV; Langkilde, AM; Correa-Rotter, R; Rossing, P; Sjöström, CD; Toto, RD; Wheeler, DC; Heerspink, HJL

Heerspink, HJL (通讯作者),Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.;Heerspink, HJL (通讯作者),George Inst Global Hlth, Sydney, NSW, Australia.

DIABETES CARE, 2023; 46 (3): 602

Abstract

OBJECTIVE To determine whether the benefits of dapagliflozin in patients with type 2 diabetes and chronic kidney disease (CKD) in the Dapagliflozin An......

Full Text Link